สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์

Printed on 22 July 2026 02:31

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To

T.MAN PHARMACEUTICAL PUBLIC COMPANY LIMITED : TMAN

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 18 record(s) found)
NameYearStatusTypePeriodAs OfDetails
T.Man Pharmaceutical Public Company Limited2026ReviewedConsolidatedQ131/03/2026
T.Man Pharmaceutical Public Company Limited2026ReviewedCompanyQ131/03/2026
T.Man Pharmaceutical Public Company Limited2025AuditedConsolidatedYear31/12/2025
T.Man Pharmaceutical Public Company Limited2025AuditedCompanyYear31/12/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ330/09/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ330/09/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ230/06/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ230/06/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ131/03/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ131/03/2025
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 12 record(s) found)
DateTimeHeadingLink
28/02/202519:16Management Discussion and Analysis Yearly Ending 31 Dec 2024
28/02/202421:44Management Discussion and Analysis Yearly Ending 31 Dec 2023 (Revised)
27/02/202621:01Management Discussion and Analysis Yearly Ending 31 Dec 2025
16/08/202319:02Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
15/05/202512:45Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
15/05/202420:37Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
14/11/202418:59Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024 (Revised)
14/11/202317:53Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
14/08/202518:26Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
14/08/202417:25Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found

Last updated on 21 July 2026